{"id":"https://openalex.org/W2953678069","doi":"https://doi.org/10.1021/acs.jmedchem.9b00711","title":"Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)","display_name":"Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)","publication_year":2019,"publication_date":"2019-06-25","ids":{"openalex":"https://openalex.org/W2953678069","doi":"https://doi.org/10.1021/acs.jmedchem.9b00711","mag":"2953678069","pmid":"https://pubmed.ncbi.nlm.nih.gov/31274313"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.9b00711","doi":"https://doi.org/10.1021/acs.jmedchem.9b00711","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.9b00711","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101755327","display_name":"Xiaohui Du","orcid":"https://orcid.org/0000-0001-5444-9434","observed_orcids":["https://orcid.org/0000-0001-5444-9434"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaohui Du","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":"https://orcid.org/0000-0001-5444-9434","affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054284746","display_name":"John E. Eksterowicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Eksterowicz","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082077159","display_name":"Haiying Zhou","orcid":"https://orcid.org/0000-0002-0440-9204","observed_orcids":["https://orcid.org/0000-0002-0440-9204"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haiying Zhou","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054539824","display_name":"Yosup Rew","orcid":"https://orcid.org/0000-0003-1155-4298","observed_orcids":["https://orcid.org/0000-0003-1155-4298"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yosup Rew","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":"https://orcid.org/0000-0003-1155-4298","affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111821232","display_name":"Liusheng Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liusheng Zhu","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086205677","display_name":"Xuelei Yan","orcid":"https://orcid.org/0000-0001-5966-8775","observed_orcids":["https://orcid.org/0000-0001-5966-8775"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xuelei Yan","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113496618","display_name":"Julio C. Medina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio C. Medina","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103239800","display_name":"Tom Hsun-Wei Huang","orcid":"https://orcid.org/0000-0001-7221-6423","observed_orcids":["https://orcid.org/0000-0001-7221-6423"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Huang","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100329932","display_name":"Xi Chen","orcid":"https://orcid.org/0000-0002-3160-614X","observed_orcids":["https://orcid.org/0000-0002-3160-614X"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xi Chen","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040589084","display_name":"Dena Sutimantanapi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dena Sutimantanapi","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029493705","display_name":"Nadine S. Jahchan","orcid":"https://orcid.org/0000-0002-0610-5001","observed_orcids":["https://orcid.org/0000-0002-0610-5001"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadine Jahchan","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070534803","display_name":"Wayne Kong","orcid":"https://orcid.org/0009-0004-5288-9814","observed_orcids":["https://orcid.org/0009-0004-5288-9814"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne Kong","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103985374","display_name":"Jessica D. Sun","orcid":"https://orcid.org/0000-0002-9844-9767","observed_orcids":["https://orcid.org/0000-0002-9844-9767"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Sun","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012260072","display_name":"Tatiana Zavorotinskaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatiana Zavorotinskaya","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045218258","display_name":"Qiuping Ye","orcid":"https://orcid.org/0009-0008-9039-0124","observed_orcids":["https://orcid.org/0009-0008-9039-0124"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiuping Ye","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059897477","display_name":"Valeria R. Fantin","orcid":"https://orcid.org/0009-0005-8328-0152","observed_orcids":["https://orcid.org/0009-0005-8328-0152"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valeria R. Fantin","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024655249","display_name":"Daqing Sun","orcid":"https://orcid.org/0000-0001-9578-8790","observed_orcids":["https://orcid.org/0000-0001-9578-8790"]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daqing Sun","raw_affiliation_strings":["ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORIC Pharmaceuticals, 240 E. Grand Avenue, Fl2, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5024655249","https://openalex.org/A5101755327"],"corresponding_institution_ids":["https://openalex.org/I4405264651"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.07155739,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"62","issue":"14","first_page":"6751","last_page":"6764"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucocorticoid-receptor-antagonist","display_name":"glucocorticoid receptor antagonist","score":0.949999988079071},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.984000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9549999833106995},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8339999914169312},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C2778826759","wikidata":"https://www.wikidata.org/wiki/Q411240","display_name":"Mifepristone","level":3,"score":0.895148754119873},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7714531421661377},{"id":"https://openalex.org/C59493245","wikidata":"https://www.wikidata.org/wiki/Q14877410","display_name":"Glucocorticoid receptor","level":3,"score":0.7268514633178711},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.6906996965408325},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6596876382827759},{"id":"https://openalex.org/C2780004078","wikidata":"https://www.wikidata.org/wiki/Q4774743","display_name":"Antiglucocorticoid","level":4,"score":0.6302647590637207},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6170516610145569},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5945795178413391},{"id":"https://openalex.org/C2780902042","wikidata":"https://www.wikidata.org/wiki/Q177911","display_name":"Steroid","level":3,"score":0.5933881402015686},{"id":"https://openalex.org/C98717036","wikidata":"https://www.wikidata.org/wiki/Q14872994","display_name":"Progesterone receptor","level":5,"score":0.48298823833465576},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.47797533869743347},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.47228294610977173},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4660402834415436},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4535055160522461},{"id":"https://openalex.org/C132040763","wikidata":"https://www.wikidata.org/wiki/Q409867","display_name":"Pregnane X receptor","level":5,"score":0.4468393325805664},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.4365120232105255},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.41437920928001404},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.37257009744644165},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.272413969039917},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.19850096106529236},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.18753266334533691},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1438165307044983},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1433693766593933},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.14145132899284363},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.14023947715759277},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.10622963309288025},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09163013100624084},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0606672465801239},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.0},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011944","descriptor_name":"Receptors, Androgen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011965","descriptor_name":"Receptors, Glucocorticoid","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011965","descriptor_name":"Receptors, Glucocorticoid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015735","descriptor_name":"Mifepristone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015735","descriptor_name":"Mifepristone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059002","descriptor_name":"Androgen Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D059002","descriptor_name":"Androgen Receptor Antagonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.9b00711","doi":"https://doi.org/10.1021/acs.jmedchem.9b00711","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.9b00711","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:31274313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31274313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1970259819","https://openalex.org/W1978919889","https://openalex.org/W1999668102","https://openalex.org/W2000737368","https://openalex.org/W2007785637","https://openalex.org/W2008339972","https://openalex.org/W2013609305","https://openalex.org/W2013980575","https://openalex.org/W2046475807","https://openalex.org/W2047160435","https://openalex.org/W2080748037","https://openalex.org/W2082755088","https://openalex.org/W2085086087","https://openalex.org/W2091718069","https://openalex.org/W2108963149","https://openalex.org/W2109882948","https://openalex.org/W2110638513","https://openalex.org/W2116919744","https://openalex.org/W2122608740","https://openalex.org/W2178537302","https://openalex.org/W2320259336","https://openalex.org/W2336040302","https://openalex.org/W2342713613","https://openalex.org/W2472770902","https://openalex.org/W2553920581","https://openalex.org/W2579864978","https://openalex.org/W2763944806","https://openalex.org/W2885336917","https://openalex.org/W2891088173","https://openalex.org/W2950993313","https://openalex.org/W2952892200"],"related_works":["https://openalex.org/W2357605690","https://openalex.org/W2030367204","https://openalex.org/W2605138000","https://openalex.org/W2031711082","https://openalex.org/W2377888108","https://openalex.org/W2037916440","https://openalex.org/W3150874355","https://openalex.org/W2094420608","https://openalex.org/W4244624886","https://openalex.org/W2018778516"],"abstract_inverted_index":{"Structure-based":[0],"modification":[1],"of":[2,11,20,28,84,113,120],"mifepristone":[3,13],"(":[4,48],"1":[5,77],")":[6,50],"led":[7],"to":[8,76,108],"the":[9,25,29,89,111],"discovery":[10],"novel":[12],"derivatives":[14],"with":[15,58],"improved":[16,65,72],"selectivity":[17,60],"profile.":[18],"Addition":[19],"a":[21,32,53,103],"methyl":[22],"group":[23],"at":[24],"C10":[26],"position":[27],"steroid":[30],"has":[31],"significant":[33],"impact":[34,112],"on":[35],"progesterone":[36],"receptor":[37,41,55],"(PR)":[38],"and":[39,63,70],"androgen":[40],"(AR)":[42],"activity.":[43],"Within":[44],"this":[45],"series,":[46],"OP-3633":[47],"15":[49,80,101],"emerged":[51],"as":[52],"glucocorticoid":[54],"(GR)":[56],"antagonist":[57,106],"increased":[59],"against":[61],"PR":[62],"AR,":[64],"cytochrome":[66],"P450":[67],"inhibition":[68,83,115],"profile,":[69],"significantly":[71],"pharmacokinetic":[73],"properties":[74],"compared":[75],".":[78],"Furthermore,":[79],"demonstrated":[81],"substantial":[82],"GR":[85,90,105,114],"transcriptional":[86],"activity":[87],"in":[88,116],"positive":[91],"HCC1806":[92],"triple":[93],"negative":[94],"breast":[95],"cancer":[96],"xenograft":[97],"model.":[98],"Overall,":[99],"compound":[100],"is":[102],"promising":[104],"candidate":[107],"clinically":[109],"evaluate":[110],"reversal":[117],"or":[118],"prevention":[119],"therapy":[121],"resistance.":[122]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-07-12T00:00:00"}